Kaitlin M Nicholson, MD

This study will explore the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) used concurrently with levonorgestrel intrauterine device in patients with poor surgical candidacy for a hysterectomy or patients who are pursuing fertility…

Investigator

Kaitlin M Nicholson

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

Female

This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine…

Investigator

Kaitlin M Nicholson

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All